Similar articles

• The DA VINCI Study: phase 2 primary results of VEGF Trap-Eye in patients with diabetic macular edema.

  Do DV, Schmidt-Erfurth U, Gonzalez VH, Gordon CM, Tolentino M, Berliner AJ, Vitti R, Rückert R, Sandbrink R, Stein D, Yang K, Beckmann K, Heier JS. Do DV, et al. Ophthalmology. 2011 Sep;118(9):1819-26. doi: 10.1016/j.ophtha.2011.02.018. Epub 2011 May 5. Ophthalmology. 2011. PMID: 21546089 Clinical Trial.
• One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.

  Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS; da Vinci Study Group. Do DV, et al. Ophthalmology. 2012 Aug;119(8):1658-65. doi: 10.1016/j.ophtha.2012.02.010. Epub 2012 Apr 24. Ophthalmology. 2012. PMID: 22537617 Clinical Trial.
• Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.

  Heier JS, Korobelnik JF, Brown DM, Schmidt-Erfurth U, Do DV, Midena E, Boyer DS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Vitti R, Berliner AJ, Zeitz O, Metzig C, Holz FG. Heier JS, et al. Ophthalmology. 2016 Nov;123(11):2376-2385. doi: 10.1016/j.ophtha.2016.07.032. Epub 2016 Sep 17. Ophthalmology. 2016. PMID: 27651226 Clinical Trial.
• Management of Diabetic Macular Edema: Is It Time to Say Goodbye to Macular Laser?

  Chen X, Modjtahedi BS, Young LH. Chen X, et al. Int Ophthalmol Clin. 2015 Fall;55(4):113-22. doi: 10.1097/IIO.0000000000000091. Int Ophthalmol Clin. 2015. PMID: 26322431 Review. No abstract available.
• A multimodal approach to diabetic macular edema.

  Au A, Singh RP. Au A, et al. J Diabetes Complications. 2016 Apr;30(3):545-53. doi: 10.1016/j.jdiacomp.2015.11.008. Epub 2015 Nov 14. J Diabetes Complications. 2016. PMID: 26853628 Review.